Men living with Crohn's disease or ulcerative colitis are usually counselled about bowel symptoms, nutrition, and medication side effects. Sexual function is discussed far less often, even though the link between inflammatory bowel disease and erectile dysfunction is one of the better documented associations in the extraintestinal literature. Pooled data across tens of thousands of patients place erectile dysfunction (ED) at roughly one in four men with inflammatory bowel disease (IBD), with substantially higher figures during active disease. The mechanisms are not mysterious, and they are not primarily psychological: chronic systemic inflammation measurably damages the vascular endothelium, and erections are an endothelial event.
Erections Are a Vascular Event Before They Are Anything Else
An erection depends on a coordinated sequence that begins in the endothelium, the single-cell lining of the arteries. Sexual stimulation triggers nitric oxide release from cavernosal nerve endings and endothelial cells. Nitric oxide activates guanylate cyclase, cyclic GMP accumulates, smooth muscle in the cavernosal arteries and trabeculae relaxes, arterial inflow increases sharply, and the expanding sinusoids compress the subtunical venules to trap blood. Every step in that chain is sensitive to nitric oxide bioavailability.
This is why erectile function behaves as a barometer for vascular health generally. The penile arteries are narrow relative to the coronary arteries, so a given degree of endothelial impairment shows up there first. The Massachusetts Male Aging Study established decades ago that ED clusters with the classical vascular risk factors rather than with age alone [6]. Anything that reduces nitric oxide availability — oxidative stress, circulating inflammatory cytokines, arterial stiffening — plausibly reduces erectile capacity, and chronic inflammatory disease supplies all three.
What the Prevalence Data Show
The largest synthesis to date pooled 14 studies and 32,858 individuals and estimated ED prevalence in men with IBD at 27% (95% CI 20–34%) [1]. That figure is notable because the cohorts skew young; in the subgroup of men under 40, pooled prevalence was 30%, far above what age-matched general population estimates would predict.
The same analysis identified three factors that meaningfully raised risk: prior surgery (OR 1.28; 95% CI 1.17–1.39), active disease (OR 2.06; 95% CI 1.07–3.05), and comorbid depression (crude OR 3.31; 95% CI 1.08–5.54) [1]. Disease activity is the recurring signal. A separate meta-analysis restricted to men with IBD reported ED in 47.6% during active disease versus 26.4% in remission, and higher rates in Crohn's disease than in ulcerative colitis. Earlier survey work in 280 men with IBD reached the same conclusion from a different direction: disease activity and depressive symptoms, not diagnosis or disease duration, were the dominant determinants of sexual function [4].
Two caveats matter for interpretation. Reported prevalence varies widely across studies — from the high twenties to over 80% — largely because of differences in how ED was defined, from single self-report questions to validated instruments such as the IIEF-5. And nearly all of this evidence is cross-sectional, which establishes association rather than causation. What the data support is that ED is common in this population, tracks with inflammatory burden, and is under-recognised in routine gastroenterology follow-up.
Inflammation, Nitric Oxide, and the Endothelial Pathway
The mechanistic case does not rest on inference. A systematic review and meta-analysis of 41 studies comparing 2,330 patients with IBD to 2,032 matched controls found significantly impaired brachial artery flow-mediated dilatation — the standard non-invasive measure of endothelial function — alongside increased carotid-femoral pulse wave velocity and greater carotid intima-media thickness [2]. In other words, men with IBD demonstrate measurably worse endothelium-dependent vasodilation, stiffer arteries, and more subclinical atherosclerosis than matched peers, independent of any sexual outcome.
The proposed pathway runs through the same cytokines that drive the bowel disease. TNF-alpha, IL-1beta, and IL-6 are elevated in active IBD, and each promotes reactive oxygen species production in endothelial cells. Superoxide reacts with nitric oxide faster than nitric oxide can act on smooth muscle, forming peroxynitrite and reducing the pool of bioavailable nitric oxide. Increased intestinal permeability adds a second input: translocation of bacterial lipopolysaccharide into the circulation produces low-grade endotoxaemia, which further activates the endothelium toward a pro-inflammatory, pro-thrombotic phenotype.
The downstream cardiovascular consequences are consistent with this. A meta-analysis of population cohorts found an increased risk of ischaemic heart disease and cerebrovascular events in patients with IBD [3]. Erectile dysfunction in this setting should therefore be treated as a potential vascular signal rather than an isolated inconvenience — a reason to review blood pressure, lipids, glucose, and smoking status, not simply to write a prescription.
Surgery, Nutrition, and Treatment-Related Contributors
Pelvic surgery introduces a distinct, non-inflammatory mechanism. The cavernous nerves and the pelvic autonomic plexus run close to the rectum, and proctectomy or ileal pouch-anal anastomosis carries a real risk of neurogenic injury. Prior operation independently raised ED risk in the pooled analysis [1]. The picture is not uniformly negative, though: in men with ulcerative colitis who had undergone ileal pouch-anal anastomosis, ED prevalence was the lowest of any subgroup at 17%, which is most plausibly explained by the removal of the inflammatory burden outweighing the surgical risk in that particular population.
Nutritional and hormonal factors compound the vascular picture. Malabsorption, chronic iron-deficiency anaemia, and low vitamin D status are common in Crohn's disease, and low-grade inflammation suppresses the hypothalamic-pituitary-gonadal axis, so testosterone at the low end of the reference range is a frequent incidental finding. Corticosteroids further suppress gonadal function during flares. None of these alone explains the prevalence figures, but each shifts the physiology in the same direction.
Depression, Fatigue, and the Psychological Load
Depression carried the strongest single association with ED in the pooled data, roughly tripling the odds [1], and cross-sectional work in IBD cohorts consistently identifies depressive symptoms as an independent predictor of sexual dysfunction alongside disease activity [4][5]. This is bidirectional and difficult to disentangle: active disease drives fatigue, pain, urgency, body-image concerns after ostomy or scarring, and anxiety about incontinence during intimacy, all of which erode sexual confidence — and sexual dysfunction in turn worsens mood.
There is a practical wrinkle. Antidepressants, particularly SSRIs, are widely prescribed in this population and independently impair erectile function and delay orgasm. When a man reports new ED shortly after starting an antidepressant, the medication deserves as much scrutiny as the bowel disease. Clinical practice has been slow here for a straightforward reason: patients rarely raise the subject, and gastroenterology consultations rarely leave room for it. Screening with a validated instrument such as the IIEF-5 takes under two minutes and identifies a problem that is treatable in most men.
Conclusion
The association between inflammatory bowel disease and erectile dysfunction is well documented, biologically coherent, and largely driven by factors that respond to treatment. Roughly a quarter of men with IBD are affected, the rate nearly doubles during flares, and the underlying endothelial impairment is measurable with standard vascular testing. The first-line response is therefore not a prescription but disease control: achieving and maintaining remission addresses the inflammatory driver, and screening for depression addresses the strongest modifiable comorbidity. PDE5 inhibitors remain effective symptomatic therapy in men with vasculogenic ED and are compatible with most IBD regimens, but they should be layered on top of adequate disease control rather than substituted for it. Any man with IBD and persistent ED warrants a cardiovascular risk assessment, a medication review, and a check of testosterone, vitamin D, and haemoglobin. More on the vascular basis of erectile function is available on the OnyxMD blog.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com, including Red Pill, an on-demand formulation of tadalafil and Pycnogenol.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
- Wu X, Zhang Y, Zhang W, et al. The Prevalence and Associated Risk Factors of Erectile Dysfunction in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. The Journal of Sexual Medicine. 2022;19(6):950-960. doi:10.1016/j.jsxm.2022.03.615
- Wu H, Xu M, Hao H, Hill MA, Xu C, Liu Z. Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(11):3179. doi:10.3390/jcm11113179
- Singh S, Singh H, Loftus EV Jr, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2014;12(3):382-393. doi:10.1016/j.cgh.2013.08.023
- Timmer A, Bauer A, Kemptner D, Furst A, Rogler G. Determinants of male sexual function in inflammatory bowel disease: a survey-based cross-sectional analysis in 280 men. Inflammatory Bowel Diseases. 2007;13(10):1236-1243. doi:10.1002/ibd.20182
- Bel LGJ, Vollebregt AM, Van der Meulen-de Jong AE, et al. Sexual Dysfunctions in Men and Women with Inflammatory Bowel Disease: The Influence of IBD-Related Clinical Factors and Depression on Sexual Function. The Journal of Sexual Medicine. 2015;12(7):1557-1567. doi:10.1111/jsm.12913
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of Urology. 1994;151(1):54-61. doi:10.1016/S0022-5347(17)34871-1
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.